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Abstract
The execution of the mitotic program with high fidelity is dependent upon precise spatiotemporal
regulation of posttranslational protein modifications. For example, the timely polyubiquitination of
critical mitotic regulators by Anaphase Promoting Complex/Cyclosome (APC/C) is essential for
the metaphase to anaphase transition and mitotic exit. The spindle assembly checkpoint prevents
unscheduled activity of APC/C-Cdc20 in early mitosis, allowing bipolar attachment of kinetochores
to mitotic spindle and facilitating equal segregation of sister chromatids. The critical effector of the
spindle checkpoint, Mitotic arrest deficient 2 (Mad2), is recruited to unattached kinetochores
forming a complex with other regulatory proteins to efficiently and cooperatively inhibit APC/C-
Cdc20. A weakened and/or dysfunctional spindle checkpoint has been linked to the development
of genomic instability in both cell culture and animal models, and evidence suggests that aberrant
regulation of the spindle checkpoint plays a critical role in human carcinogenesis. Recent studies
have illuminated a network of both degradative and non-degradative ubiquitination events that
regulate the metaphase to anaphase transition and mitotic exit. Within this context, our recent
work showed that the HECT (Homologous to E6-AP C-terminus)-family E3 ligase Smurf2 (Smad
specific ubiquitin regulatory factor 2), known as a negative regulator of transforming growth factor-
beta (TGF-β) signaling, is required for a functional spindle checkpoint by promoting the functional
localization and stability of Mad2. Here we discuss putative models explaining the role of Smurf2 as
a new regulator in the spindle checkpoint. The dynamic mitotic localization of Smurf2 to the
centrosome and other critical mitotic structures provides implications about mitotic checkpoint
control dependent on various ubiquitination events. Finally, deregulated Smurf2 activity may
contribute to carcinogenesis by perturbed mitotic control.
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The spindle assembly checkpoint
The spindle assembly checkpoint is a complex signal
transduction cascade that inhibits the metaphase to ana-
phase transition in the presence of unattached or
untensed kinetochores. It incorporates a molecular sur-
veillance mechanism whereby a single unattached kineto-
chore is sufficient to initiate a global/cell-wide inhibitory
signal to prevent the biochemical events driving anaphase
onset. The critical downstream target of the spindle check-
point is APC/C which, in association with its activator
Cdc20, is responsible for the rapid ubiquitin-dependent
degradation of mitotic regulatory proteins such as
Securin, an inhibitor of sister chromatid segregation, Cyc-
lin B, and Aurora B kinase. In early mitosis, the checkpoint
protein Mad2 is recruited to sites of unattached kineto-
chores in association with Mad1 (Mitotic arrest deficient
1), Bub1 (Budding uninhibited by benzimidazoles 1
homolog) and other components of the Mitotic Check-
point Complex (MCC). The association of Mad2 with var-
ious components of the MCC at the kinetochore is
thought to induce a dramatic conformational change of
Mad2 allowing for the tight binding between Cdc20 and
Mad2 and the inhibition of both kinetochore-associated
and cytoplasmic APC/C. This prevents premature APC/C
activity which would trigger mitotic exit and the develop-
ment of numerical chromosomal abnormalities. Implicit
in this mechanism is the requirement for reversibility,
allowing for the rapid activation of APC/C once all kine-
tochores are securely attached to spindle microtubules.
During spindle checkpoint activation, Mad2 undergoes a
dramatic conformational change from an inactive to an
active conformer capable of binding to and inhibiting
Cdc20-associated APC/C. While the evidence for the two
state model of Mad2 is abundant, the spontaneous con-
version of Mad2 from an inactive form to an active, inhib-
itory conformation takes several hours, evoking the need
for a catalytic mechanism [1]. The precise mechanisms
allowing for both the rapid reversibility and the global
nature of the inhibitory signal remain controversial, and
leading hypotheses have been recently reviewed [2,3].
It has been known for some time that rapid APC/C-medi-
ated polyubiquitination and degradation of diverse sub-
strates drives anaphase onset and the segregation of sister
chromatids. Recent work, however, has implicated non-
canonical roles for ubiquitination in the regulation of the
spindle checkpoint. Stegmeier, Reddy and others have
provided evidence for an antagonistic cycle of ubiquitina-
tion and deubiquitination of coactivator Cdc20 in early
mitosis which regulates the assembly of Cdc20-Mad2
complexes, and thereby APC/C activation and spindle
checkpoint activity [4,5]. Available evidence supports that
USP44-mediated deubiquitination stabilizes the Cdc20-
Mad2 complex by removing ubiquitin conjugates from
Cdc20 that would otherwise promote disassembly of
Cdc20-Mad2. Importantly, this work strongly implies that
the non-degradative ubiquitination of Cdc20 is a prereq-
uisite for the onset of timely APC/C activity. This must be
reconciled with recent evidence presented by Pagano and
Pines groups who argue that during spindle checkpoint
activation, a significant proportion of Cdc20 is rapidly
polyubiquitinated and degraded, perhaps in a Mad2-
dependent manner, a process which may be essential for
spindle checkpoint activation [6,7]. Taken together, these
studies suggest that an intricate network of both degrada-
tive and non-degradative ubiquitination events regulates
mitotic progression. Adding to this complexity is our
recent study indicating the activity of Smurf2, a HECT
family E3 ligase, in the stability of Mad2 and the function
of the spindle checkpoint [8].
Smurf2 targets and expanding array of diverse 
substrates
Like all HECT domain-containing ubiquitin ligases,
Smurf2 has a catalytic activity as a single polypeptide. It
contains an N-terminal C2-calcium phospholipid binding
domain, three WW domains within a flexible linker
region, followed by a C-terminal HECT domain responsi-
ble for its catalytic activity. Smurf2 was originally charac-
terized as a negative regulator of the TGF-β signaling
pathway by targeting receptors, signaling intermediates,
and other pathway-specific transcription factors for degra-
dation [9-11]. Recent studies have uncovered new roles
and substrates for this E3 beyond the canonical TGF-β sig-
naling pathway. For example, Smurf2 targets the Guanine-
Trinucleotide Phosphate hydrolase Rap1B [12], the RING
(Really Interesting New Gene-domain) protein RNF11 [13],
the Runt domain transcription factors Runx2 [14] and
Runx3 [15], Beta-catenin [16], and most recently
reported, its paralog Smurf1 [17]. Through its role as a reg-
ulator of TGF-β mediated transcriptional events, Smurf2
has been tangentially implicated in the control of the cell
cycle, but direct evidence implicating Smurf2 in cell cycle
control was lacking until recently.
Smurf2 is a novel mitotic regulator
The first clue that Smurf2 could play a more direct role in
cell cycle control came with the evidence that Smurf2 itself
is a cell cycle regulated protein. In synchronized HeLa
cells, Smurf2 protein levels are lower in late G1 and early
S and peak in late G2 and early mitosis. Whereas previous
studies had localized Smurf2 to non-clathrin containing,
caveolin- and EEA1-positive endosomes [18], our subse-
quent analyses localized Smurf2 to the centrosome by
both immunocytochemical [8] and biochemical means
(E. Osmundson, H. Kiyokawa unpublished data). Fur-
thermore, Smurf2 exhibits a highly dynamic localization
pattern throughout mitosis, moving from centrosomes in
late prophase and metaphase, to the mitotic midzone in
anaphase, and ultimately to the midbody in telophase.Cell Division 2009, 4:14 http://www.celldiv.com/content/4/1/14
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This localization pattern is reminiscent of, though not
identical to, chromosomal passenger proteins (i.e. sur-
vivin and Aurora B) which have well established roles in
mitotic regulation [19]. Consistent with this notion, our
experiments have shown that Smurf2 is required for nor-
mal mitotic progression, with acute depletion of Smurf2
in mammalian cells leading to multinucleation and cyto-
kinesis failure. Smurf2-depleted cells often initiate ana-
phase in the presence of unaligned chromosomes.
Further, following chromatin condensation in prophase,
Smurf2-depleted cells frequently fail to form a discernable
metaphase plate (i.e. chromosomal congression defects)
and exit mitosis as a bi- or multi-nucleated cell (i.e.
mitotic failure). These phenotypes suggest that Smurf2
plays a role in ensuring proper alignment of chromo-
somes at metaphase, a process controlled by the spindle
assembly checkpoint.
Cells depleted of spindle checkpoint proteins such as
BubR1 (Bub1-related kinase), Mad2, or USP44 demon-
strate mitotic defects, and fail to arrest in early mitosis in
response to spindle toxins like nocodazole or taxol. Simi-
larly, Smurf2-depleted cells also fail to arrest in promet-
aphase when exposed to nocodazole, displaying
premature degradation of the APC/C-Cdc20 substrates,
i.e., Securin, Cyclin B, and Aurora B. Co-depletion of
Smurf2 and Cdc20 can restore protein levels of these sub-
strates, confirming premature activation of APC/C. There-
fore, Smurf2 is required for the spindle assembly
checkpoint-mediated APC/C inhibition. Anaphase onset
is accelerated in Smurf2-depleted cells, which is analo-
gous to Mad2- or BubR1-depleted cells. Importantly,
Mad2 protein levels are significantly decreased and kine-
tochore localization of Mad2 is virtually undetectable in
Smurf2-depleted cells. In contrast, levels and localization
of BubR1 are essentially unaffected by Smurf2 depletion.
These data suggested that Smurf2 functions upstream of
Mad2 in spindle checkpoint control.
Smurf2-mediated control of Mad2 stability
The regulation of cellular Mad2 levels has been described
primarily in terms of transcriptional control, with recent
studies demonstrating that Mad2 is a transcriptional tar-
get of E2F, BRCA1, Myc, and most recently REST [20-23].
While Mad2 has been shown to be regulated by phospho-
rylation [24], other potential forms of post-transcriptional
modification and regulation of Mad2 have not been thor-
oughly characterized. Smurf2-mediated control of Mad2
appears to occur at the level of Mad2 protein stability [8].
While there is no change in Mad2 mRNA levels, an
increase in polyubiquitin-conjugated Mad2 protein is
observed in Smurf2-depleted cells, which is further
increased by proteasome inhibition. These observations
suggest that Smurf2 normally functions as a suppressor of
ubiquitin-dependent degradation of Mad2. Interestingly,
Smurf2 may also influence the kinetochore localization of
Mad2, since forced overexpression of Mad2 in Smurf2-
depleted cells results in a failure of exogenous Mad2 in
localizing to kinetochores in the presence of nocodazole.
The role of Smurf2 in the spindle checkpoint appears to
be mediated, at least partly, through its activity as an E3
ubiquitin ligase. Cells expressing a catalytically inactive
Smurf2 mutant (Smurf2-C716A) also exhibit mitotic
defects similar to Smurf2-depleted cells, together with pre-
mature activation of APC/C, indicating spindle check-
point dysfunction.
Two models of Smurf2-mediated control of 
Mad2 and the Spindle Assembly Checkpoint
Based on available evidence we propose two models
explaining the role of Smurf2 in mitotic checkpoint con-
trol (Figure 1). Both of these models build upon evidence
suggesting that the role of Smurf2 in the spindle check-
point is dependent upon its ubiquitin ligase activity. The
first model, hereafter designated the direct model, pro-
poses that Mad2-directed E3 ligase activity of Smurf2
functionally antagonizes a yet to be identified E3 ligase
which would otherwise promote the polyubiquitination
and degradation of Mad2 in various contexts. Given the
established importance of the active (APC/C inhibitory)
conformer of Mad2 for mitotic checkpoint function,
ongoing surveillance for a match between the conforma-
tional state of Mad2 and cellular conditions/checkpoint
status should be critical for checkpoint function. For
example, due to the partially autocatalytic mechanism of
Mad2 conformational change, the presence of the non-
inhibitory Mad2 conformer above a critical threshold dur-
ing checkpoint activating conditions would be highly del-
eterious. Consistent with the direct model, it is plausible
that Smurf2 mediated attachment of mono-ubiquitin or
non-Lys48 linked (non-degradative) ubiquitin chains
(e.g. Lys63 linkage) promotes the transition to the APC/C
inhibitory conformer of Mad2 during checkpoint activa-
tion. Such a posttranslational modification may stabilize
the hypothesized intermediate structural state of Mad2
[25] facilitating the structural rearrangements associated
with Mad2 conformational activation. In the absence of
adequate Smurf2 E3 ligase activity, the rapid degradation
of Mad2 during mitotic progression may be an adaptive
cellular response in an attempt to eliminate "misfolded"
or non-inhibitory Mad2, a condition that is maximized
during strong experimental knockdown of Smurf2. In
support of this notion, the expression of a Mad2 mutant
incapable of assuming the inhibitory conformation
results in inactivation of the spindle checkpoint [1,26,27].
Such a model also predicts that differences in the stability
of Mad2 conformers could exist depending on the activa-
tion status of the spindle checkpoint. To our knowledge
this possibility has not been directly addressed. In theCell Division 2009, 4:14 http://www.celldiv.com/content/4/1/14
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direct model, the direct ubiquitination of Mad2 by
Smurf2 would also presumably mobilize the appropriate
localization of Mad2 to unattached mitotic kinetochores.
It is of interest that a recent report described the ubiquiti-
nation of the chromosomal passenger protein survivin
occurs via both Lys48- and Lys63-linkages. The authors
demonstrate that it is the assembly and disassembly of
non-degradative Lys63 linked ubiquitin chains that
appear to be critical for its association with mitotic kine-
tochores [28]. A similar mechanism may be at play with
Mad2, whereby regulated attachment of distinct ubiquitin
linkages would specify alternative fates of Mad2 providing
yet another layer of checkpoint control.
In the second model, hereafter referred to as the indirect
model, Smurf2 catalyzes the ubiquitin-dependent degra-
dation of an unidentified E3 ligase (or its critical cofactor)
that promotes consititutive polyubiquitination of Mad2.
In this way, mitotic Smurf2 activity would antagonize the
action of this unknown E3 ligase, thereby allowing for sta-
bility and proper localization of Mad2 and a functional
spindle checkpoint. Conditions leading to decreased lev-
els or activity of Smurf2 would upregulate the activity of
this E3 ligase, targeting Mad2 for polyubiquitination and
degradation. The implications of the indirect model are
best appreciated in context of what is known about the
kinetics of Mad2 conformational interconversion. The
spontaneous reverse transition from active (inhibitory) to
inactive(non-inhibitory) Mad2 conformation is six-fold
slower than the forward reaction (which is already unusu-
ally slow at ~9 hrs), owing partly to the thermodynami-
cally favored inhibitory conformation [1]. While
p31comet-dependent mechanisms exist to block the con-
version of inactive to active Mad2 in aggregate [29-31], to
our knowledge no mechanisms have been described to
catalyze the conversion of the active conformer of Mad2
back to inactive conformer, an energetically costly proc-
ess. Alternatively, it may be more efficient for the cell to
simply bypass this problem through rapid ubiquitin-
dependent degradation of the inhibitory Mad2 conformer
once the spindle checkpoint has been satisfied, allowing
for swift and decisive anaphase onset. Given that kineto-
chore-microtubule interaction is a stochastic process, this
would occur locally on a kinetochore by kinetochore
basis. In support of this view, most Mad2 exists in the
non-inhibitory conformation in interphase cells [1], and
the inhibitory conformation of Mad2 is unlikely to exist as
a monomeric form uncomplexed with Mad2, Cdc20, or
Mad1 [32]. Viewed in this light, Smurf2 would target the
activity of this E3 ligase in early mitosis at unattached
kinetochores. As kinetochores become securely attached
to mitotic spindle, Smurf2 activity could be locally down-
Putative models depicting the role of Smurf2 in Mad2 stabilization and spindle checkpoint integrity Figure 1
Putative models depicting the role of Smurf2 in Mad2 stabilization and spindle checkpoint integrity.
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regulated or it could be sequestered from the vicinity,
which would allow for the local ubiquitin-dependent deg-
radation of the inhibitory conformer of Mad2.
It will be interesting to determine if a direct causal rela-
tionship exists between the apparent mislocalization and
instability of Mad2 in Smurf2-depleted cells. Recent work
has emphasized the importance of localization-depend-
ent activity of ubiquitin ligases (i.e. APC/C) and other par-
ticipants of the ubiquitin proteasome system [33]. It is
plausible that the destiny of Mad2, either degradation or
APC/C inhibition, could be entirely dependent upon
matching subcellular localization with mitotic state/
phase, and that Mad2 is simply degraded when it is mis-
localized. Thus the enhanced ubiquitin-dependent degra-
dation of Mad2 observed in Smurf2-depleted cells could
be entirely a result of being in the wrong place at the
wrong time. The common thread linking these two mod-
els is the unknown E3 ligase regulating the degradation of
Mad2, whose identity should be determined by future
studies.
A broader role for Smurf2 in mitosis
While defective spindle checkpoint function is likely the
major contributor to the mitotic defects in Smurf2
depleted cells, the localization pattern of Smurf2 through-
out mitosis suggests that Smurf2 plays a role downstream
of the metaphase to anaphase transition. A number of
centrosomal proteins, including centriolin and survivin,
in association with other members of the chromosomal
passenger complex, undergo traffic to the mitotic mid-
zone during anaphase and the midbody at telophase, exe-
cuting unique roles presumably at each of their successive
destinations. Furthermore, the individual depletion of
many of these proteins results in a failure of cytokinesis
and multi-nucleation possibly in spindle checkpoint-
independent manners. Thus, it is likely that post-transla-
tional modification of Smurf2 or its association with dif-
ferent cellular factors orchestrates the complex trafficking
of Smurf2 to various mitotic structures during mitosis.
Current studies are underway to examine the possibility of
mitosis-specific, perhaps spindle checkpoint-independent
roles of Smurf2.
The centrosome acts as a physical platform for the integra-
tion of multicomponent signaling cascades throughout
various phases of the cell cycle. It is noteworthy that
Smurf2 is detected at the centrosome throughout the cell
cycle, and studies thus far have only tangentially
addressed a possible role for Smurf2 at the centrosome.
Smurf2 depleted cells frequently display both numerical
and structural centrosomal abnormalities although this
could be explained by mitotic failure after normal centro-
somal duplication cycles. Furthermore, several players in
the spindle assembly checkpoint (e.g. BubR1, Cdc20,
Mad2, and now Smurf2) convene at the centrosome in
early mitosis, the significance of which remains obscure.
It is also of interest that Smurf1 controls cell polarity by
targeting RhoA for proteasomal degradation [34], and the
critical role for RhoA in cytokinesis has been established
[35]. A recent paper by Fukunaga et. al reports that Smurf2
can promote the degradation of Smurf1 to increase RhoA
signaling and promote metastatic progression [17]. While
most previous studies have shown that Smurf1 regulates
RhoA activity locally at cellular protrusions, it is plausible
that Smurf1 participates in control of RhoA signaling dur-
ing cytokinesis. Although our group did not observe any
appreciable effect of Smurf1 depletion on mitosis or cyto-
kinesis, these experiments do not rule out the possibility
that Smurf2-mediated control of Smurf1 regulates RhoA
activity during mitotic exit. It remains to be determined
whether Smurf2 is involved, either directly or indirectly,
in the regulation of RhoA during cytokinesis.
Implications for deregulation of Smurf2 during 
tumorigenesis
Genomic instability and aneuploidy are well established
properties of cancer, which are often associated with poor
prognosis of patients. It is clear that a defective spindle
checkpoint can promote genomic instability and aneu-
ploidy at the cellular level. Moreover, recent in vivo studies
have examined whether aneuploidy secondary to mitotic
checkpoint dysfunction is a predisposing event in cancer
development [36]. For example, Mad2 haploinsufficiency
causes premature anaphase onset and chromosomal
instability, which is consistent with the higher susceptibil-
ity of Mad2-heterozygous mice to lung tumorigenesis
[37]. On the other hand, transgenic mice with inducible
Mad2 overexpression also develop a variety of tumors
[38], which is consistent with Mad2 overexpression
observed in a wide range of human cancers [39]. Further-
more, mouse models with Bub1 hypomorphism [40] or
Mad1 haploinsufficiency [41] provide further evidence
that misregulation of the spindle assembly checkpoint
promotes in vivo tumorigenesis through the development
of chromosomal instability. Similarly, deregulated
Smurf2 activity beyond functionally optimal ranges may
promote cancer development with genomic instability.
Consistent with this notion, we have recently observed
that not only Smurf2 depletion but also forced expression
of wild-type Smurf2 to exceedingly high levels can perturb
the spindle checkpoint and ultimately cause multinuclea-
tion (E. Osmundson and H. Kiyokawa, unpublished
observations). This is analogous to the phenotypes of
forced overexpression of Mad2 both in vitro and in vivo.
Previously, Smurf2 has been functionally implicated in
tumorigenesis through its role as a negative regulator of
growth inhibitory TGF-β signaling. Smurf2 has beenCell Division 2009, 4:14 http://www.celldiv.com/content/4/1/14
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shown to be upregulated in esophageal carcinomas [42],
and a recent study by Jin et. al, employing a breast cancer
tissue array, showed that Smurf2 is upregulated in many
breast cancer tissues [43]. Based on their functional anal-
yses they concluded that Smurf2 activity contributes to
metastatic progression, yet likely in a manner independ-
ent of TGF-β signaling. The Oncomine database of gene
expression profiles http://www.oncomine.org also show
increased expression of Smurf2 is observed in breast,
ovary, brain and some other cancers, analogous to
increased Mad2 expression. Our recent work highlighting
the role of Smurf2 upstream of Mad2 stability control pro-
vides new insight into roles for Smurf2 in human carcino-
genesis. Viewed in this light, the overexpression of Smurf2
could provide a double-hit to cells undergoing the process
of carcinogenesis; by rendering cells unresponsive to the
tumor suppressive TGF-β signals, and by promoting spin-
dle checkpoint dysfunction and the genomic instability
characteristic of malignant phenotypes. More mechanistic
studies are needed to establish the role of deregulated
Smurf2 actions in carcinogenesis.
Conclusion
Our understanding of the spindle assembly checkpoint
has matured considerably over the past decade, owing to
the refinement of techniques to interrogate the complex
enzymatic machinery involved. Still, mechanisms
accounting for the robustness of the checkpoint as well as
those allowing for its rapid reversal need to be clearly
defined. Current evidence suggests that the dynamic
nature of checkpoint signaling balances on an axis of
ubiquitination and antagonistic deubiquitination of
Cdc20 [4,5], and on checkpoint-associated Mad2 confor-
mational change [2]. Although it is clear that spindle
checkpoint signaling is initiated at the kinetochore, subse-
quent spatiotemporal control of these two aspects of
checkpoint signaling remains obscure. Our recent data
demonstrating that the HECT E3 ligase Smurf2 partici-
pates in Mad2 posttranslational control and localization
sheds light on previously unappreciated complexities of
the spindle checkpoint involving the localization and sta-
bility of Mad2 [8]. In addition to its role as a regulator of
the spindle checkpoint, the localization of Smurf2 to
other critical mitotic structures implies its participation in
other aspects of mitotic control, perhaps occurring well
before or after the metaphase to anaphase transition. The
juxtaposition of mitotic Smurf2 functions with its estab-
lished role as a negative regulator of TGF-β signaling may
provide a mechanism for the heritability of spindle check-
point-driven epigenetic changes across mitosis into early
phases of the next cell cycle. Further experiments are
needed to delineate how the mitotic and non-mitotic
roles of Smurf2 are integrated throughout the cell cycle
(Figure 2). Finally, previous studies focusing on TGF-β
associated functions of Smurf2 suggested that Smurf2
misregulation may contribute to tumorigenesis. The role
of Smurf2 in Mad2 regulation and spindle checkpoint
control provides a new theoretical basis for tumorigenesis
occurring through Smurf2 misregulation, and these mech-
anisms should be clarified by ongoing in vivo analysis.
Given the expanding role of the spindle checkpoint as a
chemotherapeutic target, it is of continued interest to fur-
ther define the mechanisms of spindle checkpoint control
and with it the potential for revealing novel anti-cancer
therapeutic targets.
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